McKesson Shares Outstanding 2010-2025 | MCK

McKesson shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • McKesson shares outstanding for the quarter ending March 31, 2025 were 0.128B, a 4.47% decline year-over-year.
  • McKesson 2025 shares outstanding were 0.128B, a 4.47% decline from 2024.
  • McKesson 2024 shares outstanding were 0.134B, a 5.7% decline from 2023.
  • McKesson 2023 shares outstanding were 0.142B, a 7.72% decline from 2022.
McKesson Annual Shares Outstanding
(Millions of Shares)
2025 128
2024 134
2023 142
2022 154
2021 161
2020 182
2019 197
2018 209
2017 223
2016 233
2015 235
2014 233
2013 239
2012 251
2011 263
2010 273
2009 279
McKesson Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 128
2024-12-31 127
2024-09-30 129
2024-06-30 131
2024-03-31 134
2023-12-31 133
2023-09-30 135
2023-06-30 137
2023-03-31 142
2022-12-31 141
2022-09-30 144
2022-06-30 146
2022-03-31 154
2021-12-31 152
2021-09-30 156
2021-06-30 158
2021-03-31 161
2020-12-31 160
2020-09-30 163
2020-06-30 163
2020-03-31 182
2019-12-31 180
2019-09-30 183
2019-06-30 189
2019-03-31 197
2018-12-31 195
2018-09-30 199
2018-06-30 202
2018-03-31 209
2017-12-31 208
2017-09-30 210
2017-06-30 213
2017-03-31 223
2016-12-31 222
2016-09-30 228
2016-06-30 228
2016-03-31 233
2015-12-31 232
2015-09-30 235
2015-06-30 235
2015-03-31 235
2014-12-31 236
2014-09-30 235
2014-06-30 235
2014-03-31 233
2013-12-31 234
2013-09-30 233
2013-06-30 232
2013-03-31 239
2012-12-31 240
2012-09-30 240
2012-06-30 240
2012-03-31 251
2011-12-31 251
2011-09-30 250
2011-06-30 254
2011-03-31 263
2010-12-31 258
2010-09-30 262
2010-06-30 272
2010-03-31 273
2009-12-31 274
2009-09-30 271
2009-06-30 272
2009-03-31 279
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $89.188B $359.051B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $49.818B 12.34
Cardinal Health (CAH) United States $36.754B 19.25
Labcorp (LH) United States $20.653B 16.75
Straumann Holding AG (SAUHY) Switzerland $20.570B 0.00
Cooper (COO) United States $15.991B 20.61
West Pharmaceutical Services (WST) United States $15.121B 31.70
Align Technology (ALGN) United States $13.268B 26.34
Henry Schein (HSIC) United States $8.761B 15.03
Merit Medical Systems (MMSI) United States $5.604B 27.09
DENTSPLY SIRONA (XRAY) United States $3.254B 9.72
CONMED (CNMD) United States $1.785B 13.35
STAAR Surgical (STAA) United States $0.908B 0.00
Lifevantage (LFVN) United States $0.160B 16.49
Pro-Dex (PDEX) United States $0.132B 14.41